Schneider Electric Life Science Industry Ecosphere Summit was held in Wuxi. With the theme of “Creating a win-win Digital Future”, many well-known experts, customers and partners in the industry will discuss the challenges and opportunities facing the life sciences industry, focus on industry development trends, and share digital transformation ideas and latest practices.

At present, the life sciences industry is facing multiple challenges such as accelerating digitization, servitization of medical manufacturing, increasing market uncertainty and increasing requirements for sustainable development. In this regard, Mr. Pang Xingjian, senior Vice president of Schneider Electric and head of Industrial automation business in China, pointed out: “In the face of uncertainty, resilience and efficiency are the ‘way to break the game’ for enterprise development. Based on advanced digital technology and rich experience in sustainable development, Schneider Electric empowers enterprises in the life sciences industry with green intelligent manufacturing to accelerate the progress towards an open, resilient, efficient and sustainable future.”

Xingjian Pang is Senior Vice President and head of Industrial Automation in China at Schneider Electric

Experts talk about innovation and practice

At the summit, Mr. Ma Jun, vice president of Shanghai Junshi Biomedicine Technology Co., LTD., shared his thoughts on the digital transformation of biopharmaceutical enterprises, and he believed that: “The essence of enterprise digital transformation is to resolve the uncertainty of complex systems with the automatic flow of data, optimize the efficiency of resource allocation, and build new capabilities and competitive advantages in the world defined by ‘data + algorithm’. Enterprise digital transformation is not only driven by technology, but also the strategic commitment of management.”

Ma Jun, Vice President of Shanghai Junshi Biomedical Technology Co., LTD

At the roundtable “Exploration and Practice of Digital Transformation in Pharmaceutical Companies”, Schneider Electric joined forces with a number of industry experts and partners to discuss. Mr. Dong Jian, CEO of Pharmahead and senior Vice President of Pharmabio, gave an in-depth interpretation of how the pharmaceutical industry can achieve compliance, efficiency, safety, stability, green and sustainable development goals with digital capabilities. Mr. Ni Bin, Assistant President and general manager of Biomedical Division of China Electronic System Engineering Fourth Construction Co., LTD., focused on how to build a future-oriented pharmaceutical enterprise based on the different development stages and differentiated concerns of the enterprise. Focusing on the technology field, Dr. Ren Chao, director of manufacturing industry of Huawei Centeng Computing business, shared advanced technologies such as AI drug research and development, AI visual quality inspection, and discussed how to use technical capabilities and platform advantages to empower pharmaceutical companies to transform.

“Exploration and Practice of digital transformation of pharmaceutical enterprises”

As a global expert in digital transformation in the field of energy management and automation, Schneider Electric is providing strong support to enterprises from multiple dimensions and levels to build a digital future. Mr. Peidong Wang, General Manager, Life Sciences Industry, Schneider Electric Industrial Automation End-User Business, said: “The digital transformation of enterprises in the life science industry should start from the application scenario and cover the whole life cycle of the industry. Schneider Electric builds an integrated operation center by virtue of consulting services, integrated design, asset information management center and operation information management center, intelligent facilities, and efficient operation, and actively lays out the life science industry track. Meet the diversified needs of enterprises to accelerate research and development, compliance, stable production, and efficiency, and help the industry accelerate digital transformation.”

Peidong Wang is General Manager, Life Sciences Industry, Schneider Electric’s Industrial Automation End-User Business

From consulting to landing, all-round empowerment

At the summit, Schneider Electric comprehensively demonstrated EcoStruxureTM solutions for the life sciences field, combining 7 solutions and 6 differentiated values to meet the needs of enterprises in various dimensions such as facilities, research and development, sustainability, and ensure strict quality control, while helping production and operation to continue compliance:

Leading by top-level planning, drawing a clear blueprint: Schneider Electric digital transformation consulting services focus on lean production, supply chain collaboration, production optimization, smart factory planning, energy efficiency dual carbon, electrical safety, power quality and microgrid eight application scenarios, describing a clear roadmap from strategic planning to implementation;
Full life cycle solutions, one-stop support for transformation and upgrading: covering the full life cycle solutions of project design, construction, operation and maintenance, providing strong technical support for enterprises’ digital transformation, not only ensuring that the project is delivered on time and on quality within the controllable planning time and budget, but also helping to improve efficiency and ensure asset reliability and availability during the operation phase;
Open the double base of data to promote the development of digital factory: Integrating engineering and operation data, Schneider Electric helps enterprises dig deep into the value of data in all links from research and development, testing to commercial production, maximize synergies, improve the management efficiency and efficiency of pharmaceutical enterprises, and support the sustainable development of digital factory.

Schneider Electric Life Science industry total solution overview

Accelerate digital transformation from smart facilities to efficient operations

Focusing on smart facilities and efficient operation, Schneider Electric brought two wonderful keynote speeches at the summit site, providing enterprises with safe compliance, efficient production and operation, green and sustainable digital solutions:

Smart Facility Solutions Build digital cornerstones: Schneider Electric’s Smart Facility solutions (BMS&EMS, PAS/DCS, SCADA, EMS+, etc.) will enable pharmaceutical companies to achieve compliant manufacturing, deep integration, monitoring, reduced non-failure downtime, and lower operating and maintenance costs. Aiming at the common pain points in the pharmaceutical packaging process, the Lexium MC12 flexible conveying system will effectively improve the performance and flexibility of the product conveying system, achieve efficient operation and maintenance, and enhance economic benefits while ensuring quality and safety.
Efficient operational solutions for digital control: Through full life cycle efficient operation solutions (cockpit, integrated operations center UOC, integrated design AVEVA E3D, asset information management AVEVA AIM and operations information management AVEVA PI System, EBR, MES, etc.) to drive digital production with compliance data, Reduce operational deviations and errors, ensure compliance and transparency, further ensure operational safety, reduce operational costs, and achieve visibility, control and digitalization.
At the summit, the participants visited Schneider Electric Wuxi Innovation Demonstration Park online and walked into the end-to-end “Lighthouse factory” to fully understand how digital technology can penetrate all aspects of procurement, production and delivery, achieve comprehensive cost optimization through an efficient and agile end-to-end value chain, and create a competitive advantage for sustainable growth.

Facing the future, Schneider Electric will continue to deepen the life science industry, work with partners to create a safe and compliant, stable and reliable, efficient and flexible, green and low-carbon process and environment, seize industrial development opportunities, achieve a double harvest of economic and social benefits, and accelerate towards the digital future of “smart pharmaceuticals”.